# DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
> **ANDA215997** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM INDS INC · Approved 2023-09-27
## Drug
- **FDA Application Number:** ANDA215997
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
- **Generic name:** DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE
- **Active ingredients:** AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SUN PHARM INDS INC
- **Manufacturer:** Sun Pharmaceutical Industries, Inc.
- **First approval:** 2023-09-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215997)
---
*AI Analytics · CC0 1.0*